1. Kenneth O. Beyersdorf
1402 Lake Tapps Pkwy E #104, PMB 159, Auburn, WA, 98092
kbeyersdorf@hotmail.com
253-347-9612
Biotech and Pharmaceutical Objective: To obtain a new product launch, orphan and rare
disease sales/marketing position in the biotech sector that offers an opportunity for growth and
the ability to advance my career both domestically and internationally.
Professional Profile:
Awards and Acomplishments:
 2015 1st
half Acthar RSU winner #20/84
 2013 Acthar sales 800% of plan over baseline.
 2011 Q4 Benlysta Sales Growth Award Winner - Top 15 in the nation.
 2010 hired by Human Genome Sciences out of over 3,500 applicants to launch Benlysta,
the first new approved SLE mediation in 56 years.
 2009 lead Seattle South Territory through multiple challenges bringing the territory from
78% to plan Q1/Q2 to 124% to plan Q3/Q4.
 2009 2 time Sales Excellence Award Winner
 2007 Biogen Idec Rheumatology Leadership Circle (Presidents Club) winner.
 2006 successfully planned and delivered our Rituxan for RA launch.
 12 years of biotech/pharmaceutical sales experience with a record of successfulbiotech
drug launches and sales excellence.
Professional Attributes
 Experienced in multiple successfulfirst-in-class biotech product launches in
Rheumatology, Nephrology, Gastroenterology/Hepatology and Orphan Drug/Rare
Disease.
 Fluid in all aspects of launching and selling injectable and infusible specialty biologic
drugs including- specialty pharmacy, administration, purchasing, reimbursement and
access in a buy and bill setting.
 Developing processes for managing patient flow in complex selling environments -
specialty pharmacy and buy and bill.
 Self-starter with an effective combination of business acumen, organizational, planning
and communication skills.
 Articulate, persuasive and quick thinking with the ability to connect all personality types.
 Team player, experienced in integrating all business and clinical units into the account
call process.
Work Experience:
Questcor/Mallinckrodt: Acthar Specialist/Rheumatology Oct 29th
– Present
 2015 150% Q1 and Q2 goal attainment.
 2015 selected by PsA Product Management team to aid in developing PsA launch
strategy for physician, nurses and patients.
 2015 1st
half Acthar RSU winner. #20/84. #3/7 in region.
 2014 more than doubled my Acthar referralvolume over 2013.
 2014 selected to work the ACR Winter Medical Conference in Maui
 2013 achieved 800% of goal attainment to my launch year baseline. #3/7 in region

2.  2013 had an 86.4% Approved/Shipped rate.
 2013 selected to work the ACR Medical Conferences in San Diego
 Identified and developed 3 regional thought leaders as speakers.
 Launched Acthar for Poly and Dermatomyositis in Western Washington and Alaska.
 Successfully and strategically navigated an extremely difficult Acthar payer landscape in
the Pacific Northwest using my customer relationships and my Acthar Reimbursement
Team.
Human Genome Sciences: Account Manager Oct. 2010 – Oct. 2012
 Lunched, managed and sold IV Benlysta for SLE in Washington and Alaska finishing
2011 ranked 3rd
in the Pacific NW District and top half of the country.
 Utilized my relationships, clinical selling skills and business acumen to gain formulary
access for Benlysta in ALL MAJOR Seattle/Tacoma area hospitals within 5 months of
approval.
 Had #1 account for Benlysta usage in the Pacific NW District – The Seattle Arthritis
Clinic – in 2011.
 Facilitated Benlysta infusions in 24 offices and hospitals Launch-To-Date.
 Won National Growth Award for Q4 2011.
 Sold over $1.7 million dollars of Benlysta Launch-To-Date.
 Nominated to represent the Pacific NW District on HGS’s special FIT Marketing Task
Force – a group comprised of district leaders to act as a liaison between marketing and
field sales.
Biogen Idec: Rheumatology Area Business Manager Jan. 06 – Oct. 10
 Launched, managed and sold IV Rituxan for RA in Washington and Alaska finishing
year 1 ranked #22 out of 65 territories.
 Managed and developed clients in rheumatology offices and hospitals, working with
inpatient and outpatient infusions and reimbursement.
 2007 Leadership Circle winner ranked #6 in the Nation.
 2009 lead Seattle South Territory through multiple challenges bringing the territory from
78% to plan Q1/Q2 to 124% to plan Q3/Q4.
 Spearheaded and lead the launch of our NHL Co-Pay Assistance Program in shared
accounts with my Oncology partner.
 Responsible for the successfulmanagement of the Seattle South Territory which
encompasses Eastern Washington and Alaska requiring extensive travel and planning.
 Appointed as the West Region’s ABM to work on 2 Pilot Sales Teams geared placing
Rituxan hirer in the physician’s treatment algorithm and breaking TNF Cycling.
Intermune/Valeant: Hepatology Clinical Specialist Sept. 04 – Jan 06
 Hired Sept. 04 as part of Intermune's Hepatology sales team responsible for re-launching
Infergen for Hepatitis C.
 Aid trial sites with recruiting. Sites included the University of Washington and Tacoma
Digestive Disease Center.
 Responsible for the first Infergen patient start at the University of Washington outside of
a study protocol in December,2004, something that the company was unable to initiate
the previous 3 years.
 Worked closely with specialty pharmacy to insure benefit verification and patient access.
 More than doubled the Infergen prescriber base from 6 to 14.

3.  Successfuleducational program recruiter with an average attendance of over 25
Physicians, NP’s and PA’s - 13 attendees higher than the national average.
 2005 West Region MVP - Voted on by my peers.
 Responsible for the recruitment and speaker training of key local opinion leaders
who specialize in the treatment of Hepatitis C.
Schering Plough: Schering Labs PharmaceuticalSales Nov. 99 – Feb. 04
 Fields/Physicians worked with: Allergy & Asthma, Pulmonology, ENT, Cardiology,
Hospital, Family/Internal Medicine.
 Regional Trainer (District leadership position).
 #1 or #2 in market share or market share change each month for 4 years with at least one
product in District.
 Highest paid rep in Western Washington 2001 and 2002.
 Grew Clarinex to its highest market share ever in 2003, despite Claritin going OTC and
major managed care disadvantages.
 Everett Clinic Point Person in charge of gaining access for samples, product on clinic
formulary and detailing.
 Devised Pharmacy call plan and strategy implemented for all reps in Washington and
Alaska.
 Participated in two drug launches -Tequin & Clarinex
 Built relationships with doctors, key office personnel, Pharmacy Managers,Pharm Techs
and Regional Pharmacy Managers,which have drove market share.
RHD Window & Door Sales: Owner Sept. 98 – Oct. 99
Prospect and solicit new clients on a daily basis. Educate and market a new line of windows to
Puget Sound area contractors and developers. Negotiate pricing with window and door line
manufacturers and prospective clientele.
SportsRadio 950 KJR AM: Sports Talk Show Host and Reporter Oct. 95 – Sept. 98
Co-host nightly sports talk show. Wrote & anchored tri-hourly sports reports. Host a weekly
thoroughbred handicapping show, Seattle Mariner post game shows, the Mike Price Cougar
Coach’s show and fill-in talk show host duties.
Pioneer Radio and Sports: Account Executive Jan. 98 – Aug. 98
Sold radio advertising during sporting events for UW Baseball and Softball games, PLU & UPS
Football, Oakland A's Baseballand approximately 13 other Minor League Baseball Broadcast
throughout the country. (I worked this day job while co-hosting the evening show on Sports
Radio)
Fox Communications: Account Executive Aug. 96 – March 97
Top inside and outside sales representative for seven consecutive months. Sold Internet, cellular,
paging and business and residential long distance phone services. Utilized my excellent
persuasion skills to get businesses and individuals to switch services to Fox by gaining their trust
and selling the benefits of the company. (I worked this day job while co-hosting the evening
show on Sports Radio)
Education and Training:
 Washington State University, BA Communications/Broadcasting 1995
Foreign Language Proficiency:

4.  Italian - Mastery of Italian Language, Dante Alighieri Society 2009